Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
30.70
+1.17 (3.96%)
At close: Jul 20, 2026, 4:00 PM EDT
31.19
+0.49 (1.61%)
After-hours: Jul 20, 2026, 7:58 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.94 billion as of July 20, 2026. Its market cap has increased by 237.44% in one year.
Market Cap
1.94B
Enterprise Value
1.49B
1-Year Change
237.44%
Ranking
Category
Stock Price
$30.70
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.94B, an increase of 186.52%. That is a compound annual growth rate of 76.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.94B | -0.56% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.96B |
| Damora Therapeutics | 1.94B |
| Nanobiotix | 1.91B |
| Tyra Biosciences | 1.91B |
| Taysha Gene Therapies | 1.91B |
| Kardigan | 1.89B |
| Maravai LifeSciences Holdings | 1.87B |
| Bicara Therapeutics | 1.82B |